Responsible for 400,000 deaths each year globally, air pollution has yet to be sufficiently addressed by the world's governments, researchers have warned. EurActiv France reports.
Air pollution damages the heart. According to an expert position paper published in the European Heart Journal, many types of cardiovascular disease are linked to poor air quality.
The most significant announcement that Apple made in 2014 wasn’t a larger-sized iPhone. It was that Apple is entering the health-care industry. With HealthKit, it is building an iTunes-like platform for health; Apple Watch is its first medical device. Apple is, however, two steps behind Google, IBM and hundreds of startups. They realized much earlier that medicine is becoming an information technology and that the trillion-dollar health-care market is ripe for disruption.
Get ready for an influx of venture funding in healthcare software. Especially to startups whose founders have prior experience at well-known companies.
A case in point is Boston-area startup Par8o (“par-eight-oh”), which said today it has raised a $10.5 million Series A funding round. The company’s investors include Atlas Venture (the tech side of the firm), Founder Collective, CHV Capital, and Allscripts.
For obvious reasons, hospitals are a hotspot for germ exposure, which can increase the risk of infection for those making a visit by up to 10 percent, according to a recent study. What might be surprising though, is that researchers found more bacteria colonization on the hospital elevator buttons than even on the facility’s toilets.
Several potentially transformative treatments for cancer and HIV face a common obstacle—getting drugs into cells, which are designed to reject foreign materials.
A new microfluidic device, recently developed by a startup called SQZ Biotech, can get microscopic material into cells quickly and cheaply by vigorously squeezing those cells, temporarily making their membranes permeable.
The year began with a landmark event. A decade after the first human genome was decoded at a cost of about $3 billion, the sequencing-machine company Illumina, of San Diego, introduced a new model, the Hyseq X-10, that can do it for around $1,000 per genome.
INNES, siglas de plataforma Inteligente para la Innovación Estratégica, es un proyecto dirigido a integrar diferentes servicios para la automatización de los procesos de vigilancia competitiva y de tendencias, facilitando la elaboración de informes de prospectiva con el objetivo de mejorar los procesos de toma de decisiones.
An Iranian scientist claimed this week that he had invented a radar system which can detect drug addicts from nearly a mile away, and measure the level of narcotics flooding their system.
According to the Iranian Mehr news agency, the system was designed to identify explosives and bodies buried under rubble, as well as alcohol and drugs.
Scientist Seyed Ali Hosseini told the news agency on Tuesday that the technology can locate drug addicts from 1,500 meters (0.9 miles away). He said the “radar tracker was designed and built to detect drugs, explosives, bodies alive and dead under the rubble, addictive drugs and alcoholic beverages.”
San Diego-based AltheaDx, which uses diagnostic tests and bioinformatics to help doctors identify the optimal drugs based on a patient’s genetic make-up, plans to raise as much as $69 million in an IPO.
The company, which began operating in 2008, says in its IPO filing that it has used its IDgenetix technology to complete tests on more than 13,500 patient samples through the first nine months of the year. More than half of those were done in the third quarter.
